Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Keam, Susan J.
230  Ergebnisse:
Personensuche X
?
1

Resmetirom: First Approval:

Keam, Susan J.
Drugs.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Cefepime/Enmetazobactam: First Approval:

Keam, Susan J.
Drugs.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

Lifileucel: First Approval:

Keam, Susan J.
Molecular Diagnosis & Therapy.  28 (2024)  3 - p. 339-344 , 2024
Link: https://doi.org/10.1007/..
 
?
4

Nirogacestat: First Approval:

Keam, Susan J.
Drugs.  84 (2024)  3 - p. 355-361 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Berdazimer Topical Gel, 10.3%: First Approval:

Keam, Susan J.
Drugs.  84 (2024)  3 - p. 363-368 , 2024
Link: https://doi.org/10.1007/..
 
?
6

Lebrikizumab: First Approval:

Keam, Susan J.
Drugs.  84 (2024)  3 - p. 347-353 , 2024
Link: https://doi.org/10.1007/..
 
?
7

Tabelecleucel: First Approval:

Keam, Susan J.
Molecular Diagnosis & Therapy.  , 2023
Link: https://doi.org/10.1007/..
 
?
8

Mirikizumab: First Approval:

Keam, Susan J.
Drugs.  83 (2023)  11 - p. 1045-1052 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Sulbactam/Durlobactam: First Approval:

Keam, Susan J.
Drugs.  83 (2023)  13 - p. 1245-1252 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Correction to: Efanesoctocog Alfa: First Approval:

Keam, Susan J.
Drugs.  83 (2023)  10 - p. 953-953 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Cantharidin Topical Solution 0.7%: First Approval:

Keam, Susan J.
Pediatric Drugs.  26 (2023)  1 - p. 95-100 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Efanesoctocog Alfa: First Approval:

Keam, Susan J.
Drugs.  83 (2023)  7 - p. 633-638 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Sovateltide: First Approval:

Keam, Susan J.
Drugs.  83 (2023)  13 - p. 1239-1244 , 2023
Link: https://doi.org/10.1007/..
 
?
14

Correction to: Concizumab: First Approval:

Keam, Susan J.
Drugs.  83 (2023)  13 - p. 1253-1254 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Momelotinib: First Approval:

Keam, Susan J.
Drugs.  83 (2023)  18 - p. 1709-1715 , 2023
Link: https://doi.org/10.1007/..
 
1-15